TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 48 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,391,190 | $29,493,000 | 22.62% |
| Octagon Capital Advisors LP | 320,440 | $6,793,000 | 1.41% |
| Artal Group S.A. | 1,040,882 | $22,067,000 | 0.45% |
| Alphabet Inc. | 640,882 | $13,587,000 | 0.28% |
| Nantahala Capital Management | 432,072 | $9,160,000 | 0.26% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $10,600,000 | 0.22% |
| TimesSquare Capital Management, LLC | 683,400 | $14,488,000 | 0.12% |
| Perceptive Advisors | 640,880 | $13,586,000 | 0.09% |
| Virtus ETF Advisers LLC | 8,697 | $184,000 | 0.08% |
| Granite Point Capital Management, L.P. | 50,000 | $1,060,000 | 0.04% |